Abbott ABT Derivatives, gross, liabilities
Derivatives, gross, liabilities at other companies
Other financials
Where this comes from
Reported directly by Abbott in its filing.
Tagged under the XBRL concept us-gaap:DerivativeFairValueOfDerivativeLiability.
The official record: Abbott’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Abbott's derivatives, gross, liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Abbott's derivatives, gross, liabilities?
- Abbott (ABT) reported derivatives, gross, liabilities of $876M in Q1 2026.
- How has Abbott's derivatives, gross, liabilities changed year-over-year?
- Abbott's derivatives, gross, liabilities increased by 0.5% year-over-year, from $872M to $876M.
- What is the long-term trend for Abbott's derivatives, gross, liabilities?
- Over 4 years (2021 to 2025), Abbott's derivatives, gross, liabilities has grown at a 10.0% compound annual growth rate (CAGR), from $618M to $905M.